Type 2 Diabetes Self-management Intervention for Low-income Women
NCT ID: NCT01284465
Last Updated: 2015-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2011-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Partners in Care Diabetes Self-management Intervention
NCT01235429
Breaking Down Barriers to Diabetes Self-Care
NCT00142922
Social Support Intervention for Self-management of Type 2 Diabetes Mellitus
NCT04491253
Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills
NCT02128854
Empowering Rural African American Women and Communities to Improve Diabetes Outcomes
NCT01806194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is a 12-month randomized controlled trial designed to compare a lifestyle intervention group (combination group) and a control group (education only group). Participants assigned to either group will receive three group education sessions (baseline, 3 and 6 months) with an emphasis on self-management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Education and patient liaison combination
Education and patient liaison combination
Group education sessions with Patient liaison using ecological momentary assessment principles
Control group
Education only
Control group
Group education sessions at baseline, 3 and 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education and patient liaison combination
Group education sessions with Patient liaison using ecological momentary assessment principles
Control group
Group education sessions at baseline, 3 and 6 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At risk of developing diabetes related complications (treatments goals from The American Diabetes Association Standards of medical care) as defined by:
* HbA1c \>8.0 %
* Any of the metabolic clusters such as Pre-prandial plasma glucose \> 130 mg/dl; Obesity (BMI \>25 kg/m2, or waist circumference \>88 cm (\>35 in); Hypertension (Systolic \>130 and Diastolic \> 80 mmHg); Hyperlipidemia (Triglycerides \>150 mg/dL; HDL\<50 mg/dL; LDL \>100 mg/dL)
Exclusion Criteria
21 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Research Resources (NCRR)
NIH
Meharry Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sylvie Akohoue
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie A Akohoue, PhD
Role: PRINCIPAL_INVESTIGATOR
Meharry Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meharry medical College
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
081204AAH231 26
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.